Yangxun Pan

机构：Sun Yat-sen University, Karolinska Institutet, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China · ORCID：0000-0002-3887-5852

发表论文 89 篇 · 总被引 880 次 · h-index 18

代表论文

• YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment (2024 · Molecular Cancer · 被引 31)
• Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma (2025 · Radiology · 被引 22)
• Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study (2024 · International Journal of Surgery · 被引 13)
• Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study (2024 · International Journal of Surgery · 被引 9)
• Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort study (2024 · BMC Cancer · 被引 7)
• Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study (2025 · Liver Cancer · 被引 6)